Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Director/PDMR Shareholding

1 Sep 2016 07:00

RNS Number : 6240I
Lakehouse plc
01 September 2016
 

LAKEHOUSE PLC

 

 

DIRECTOR/PDMR SHAREHOLDING

Released: 1 September 2016

 

 

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Robert Holt

2.

Reason for the notification

(a)

Position/status

Executive Chairman (PDMR)

(b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Lakehouse plc

(b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument

An option to acquire ordinary shares of 10p each in the capital of Lakehouse plc ("Shares")

 

Identification code

GB00BSKS1M86

(b)

Nature of the transaction

Grant of an award structured as a nil-cost option (with zero exercise price per Share) over 2,307,692 Shares ("Award"), under, and subject to, the terms of the Lakehouse plc Special Incentive Award Plan ("Plan"). The number of Shares in respect of which the Award may ultimately be exercised will be dependent upon the extent to which the performance conditions set out in the Plan are satisfied but in all circumstances cannot exceed 4,615,384 Shares (maximum vesting if the performance conditions are met in full). The Award will normally become capable of exercise on the day after the first to occur of: (i) 31 January 2019; or (ii) the date that the audited financial results for the Financial Year ending 30 September 2018 are published ("Vesting Date") and will cease to be capable of exercise (and lapse) on the day immediately before second anniversary of such Vesting Date.

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil per Share

2,307,692

(d)

Aggregated information

N/A - single transaction

(e)

Date of transaction

31 August 2016

(f)

Place of transaction

United Kingdom

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAXPFDDEKEFF
Date   Source Headline
26th Apr 20231:59 pmRNSForm 8.3 – Sureserve Group plc – Christine Jones
26th Apr 202310:40 amRNSForm 8.3 - Sureserve Group Plc
26th Apr 20238:03 amGNWForm 8.5 (EPT/RI) - Sureserve Group Plc
25th Apr 20233:48 pmRNSForm 8.3 - Sureserve
25th Apr 20231:00 pmRNSForm 8.3 - Sureserve Group Plc
25th Apr 202311:53 amRNSForm 8.3 - Sureserve Group plc
25th Apr 202310:30 amRNSForm 8.3 - Sureserve Group Plc
25th Apr 20239:04 amRNSForm 8.3 - Sureserve Group PLC
25th Apr 20238:38 amGNWForm 8.5 (EPT/RI) - Sureserve Group Plc
24th Apr 20233:12 pmGNWForm 8.3 - Sureserve Group plc
24th Apr 20231:59 pmRNSForm 8.3 - [offeree/offeror]
24th Apr 20231:57 pmRNSForm 8.3 - Sureserve Group PLC
24th Apr 20231:28 pmRNSForm 8.3 - Sureserve Group plc
24th Apr 202311:45 amEQSForm 8.3 - Maitland Institutional Services Limited: Re Sureserve Group PLC
24th Apr 202311:19 amRNSForm 8.3 - Sureserve Group Plc
24th Apr 202311:17 amRNSForm 8.3 - Sureserve Group plc
24th Apr 202310:24 amGNWForm 8.5 (EPT/RI) - Sureserve Group Plc
24th Apr 20239:33 amGNWForm 8.3 - [SURESERVE GROUP PLC - Opening Declaration - 21 04 2023] - (CGAML)
21st Apr 20232:22 pmRNSForm 8.3 - Sureserve Group Plc
21st Apr 20239:24 amRNSForm 8.3 - Sureserve Group plc
21st Apr 20237:00 amRNSRecommended Cash Acquisition
21st Mar 20231:47 pmRNSResult of AGM
21st Feb 20237:00 amRNSHolding(s) in Company
20th Feb 20234:31 pmRNSHolding(s) in Company
16th Feb 20237:05 amRNSAnnual Report and Accounts and Notice of GM
24th Jan 20237:00 amRNSFinal Results
16th Jan 20233:36 pmRNSTotal Voting Rights
3rd Jan 20239:08 amRNSExercise of Options and Total Voting Rights
15th Dec 202211:52 amRNSShare issue
13th Dec 20229:07 amRNSGrant of Options
16th Nov 202212:02 pmRNSExercise of Options and Total Voting Rights
13th Oct 202211:59 amRNSExercise of Options and Total Voting Rights
11th Oct 20227:00 amRNSPost Year-End Trading Update
5th Oct 20227:00 amRNS£5.4m Contract & Completion with the DIO and MoD
21st Sep 20223:52 pmRNSTotal Voting Rights
9th Aug 20225:15 pmRNSExercise of Options and Total Voting Rights
3rd Aug 20227:00 amRNSExercise of Options and Total Voting Rights
1st Jul 20224:02 pmRNSHolding(s) in Company
20th Jun 20229:13 amRNSExercise of Options and Total Voting Rights
16th Jun 20229:09 amRNSTotal Voting Rights
6th Jun 20229:11 amRNSDirector/PDMR Shareholding
26th May 20222:08 pmRNSDirector/PDMR Shareholding
18th May 202211:48 amRNSTransaction by Director / PDMR
17th May 20227:00 amRNSInterim Results
11th May 20228:05 amRNSExercise of Options and Total Voting Rights
9th May 20227:00 amRNS8 Year Contract Extension worth £68m with L&Q
5th May 20227:00 amRNSAppointment of Non-Executive Director
3rd May 20227:00 amRNSNotice of Investor Presentation
14th Apr 20227:00 amRNSNotice of Interim Results
13th Apr 20227:00 amRNSAppointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.